Abbott FreeStyle Lite monitor:
This article was originally published in Clinica
Executive Summary
Abbott Diabetes Care will release in the US next month its FreeStyle Lite blood glucose monitor for diabetics, after receiving 510(k) market clearance for the product. The device has an automatic calibration feature that eliminates the manual coding step usually required by most blood glucose meters before starting a new vial of test strips, Alameda, California firm claimed. It is easy to use and will allow users to test their blood quickly, it added.
You may also be interested in...
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.